Free Trial

Analysts Set Expectations for Health In Tech Q1 Earnings

Health In Tech logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research projects Health In Tech will post a Q1 2026 EPS of ($0.04) and forecasts a recovery across the year to a full-year FY2027 EPS of $0.17, with Q2–Q4 2026 estimates moving from ($0.03) to $0.04.
  • In the most recent quarter Health In Tech reported EPS of ($0.01) (meeting estimates) on $7.51 million of revenue, and the stock trades around $1.42 with a market cap of about $80.8 million and a high beta of 7.89.
  • Several institutional investors have recently initiated positions, including Renaissance Technologies, Two Sigma, XTX Topco, Ancora Advisors and Jane Street, indicating growing institutional interest.
  • Interested in Health In Tech? Here are five stocks we like better.

Health In Tech, Inc. (NASDAQ:HIT - Free Report) - Equities research analysts at Zacks Research issued their Q1 2026 EPS estimates for shares of Health In Tech in a note issued to investors on Wednesday, April 1st. Zacks Research analyst M. Marin forecasts that the company will earn ($0.04) per share for the quarter. Zacks Research also issued estimates for Health In Tech's Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at $0.03 EPS, Q4 2026 earnings at $0.04 EPS and FY2027 earnings at $0.17 EPS.

Health In Tech (NASDAQ:HIT - Get Free Report) last announced its earnings results on Wednesday, March 25th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). The company had revenue of $7.51 million for the quarter.

Health In Tech Stock Down 2.1%

NASDAQ:HIT opened at $1.42 on Thursday. The stock has a market cap of $80.81 million, a price-to-earnings ratio of 71.00 and a beta of 7.89. The company's 50 day moving average price is $1.42 and its 200-day moving average price is $1.93. Health In Tech has a 52 week low of $0.51 and a 52 week high of $4.02.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HIT. Renaissance Technologies LLC purchased a new stake in Health In Tech in the 4th quarter worth $214,000. XTX Topco Ltd bought a new position in Health In Tech in the fourth quarter worth about $203,000. Ancora Advisors LLC purchased a new stake in shares of Health In Tech during the third quarter worth about $389,000. Two Sigma Investments LP acquired a new stake in shares of Health In Tech during the third quarter worth about $386,000. Finally, Jane Street Group LLC purchased a new stake in Health In Tech in the 1st quarter worth approximately $48,000.

About Health In Tech

(Get Free Report)

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Health In Tech Right Now?

Before you consider Health In Tech, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health In Tech wasn't on the list.

While Health In Tech currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines